 |
|
|
| |
ENDURANCE-2: Safety and Efficacy of Glecaprevir/Pibrentasvir in Hepatitis C Virus Genotype 2-infected Patients without Cirrhosis: a Randomized, Double-Blind, Placebo-Controlled Study
|
| |
| |
Reported by Jules Levin
AASLD 2016 Nov 11-15 Boston, MA
Kris V Kowdley1, Massimo Colombo2, Neddie Zadeikis3, Parvez S Mantry4, Filipe Calinas5, Humberto Aguilar6, Victor de Ledinghen7, Yves Horsmans8, Yiran Hu3, Teresa I Ng3, Federico Mensa3
|
| |
|
|
|
|
|
